Send us Feedback

GlaxoSmithKline (GSK)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
(Latest | Earliest) View (previous 50) (next 50)

Diff selection: mark the radio boxes of the versions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with current version, (last) = difference with preceding version, M = minor edit.

(cur)(last)01:14, June 12, 2012192.193.116.143 (Talk) (→Seretide/Advair (GBP 5.1 Billion))
(cur)(last)21:17, May 1, 2011Smedoff (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)21:16, May 1, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)19:53, March 26, 2011Smedoff (Talk | contribs)[stable]
(cur)(last)02:32, February 28, 201194.170.25.150 (Talk) (→History)
(cur)(last)03:29, January 20, 2011Kkparikh (Talk | contribs) (→Research and Development)[stable]
(cur)(last)06:57, November 30, 2010Kkparikh (Talk | contribs) (→Recent News)[stable]
(cur)(last)06:36, November 30, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)06:36, November 30, 2010Kkparikh (Talk | contribs) (→Recent News)[stable]
(cur)(last)06:35, November 30, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)06:32, November 30, 2010Kkparikh (Talk | contribs) (→Recent News)[stable]
(cur)(last)23:50, November 7, 2010Kkparikh (Talk | contribs) (→Recent News)[stable]
(cur)(last)23:38, November 7, 2010Kkparikh (Talk | contribs) (→Research and Development)[stable]
(cur)(last)22:56, November 7, 2010Kkparikh (Talk | contribs) (→Business Segments)[stable]
(cur)(last)22:42, October 24, 2010Kkparikh (Talk | contribs) (→Business Growth)[stable]
(cur)(last)12:33, October 14, 2010Corinnetu (Talk | contribs) (→Flu Pandemics/Epidemics)[stable]
(cur)(last)12:32, October 14, 2010Corinnetu (Talk | contribs) (→Flu Pandemics/Epidemics)[stable]
(cur)(last)12:29, October 14, 2010Corinnetu (Talk | contribs) (→Business Segments)[stable]
(cur)(last)19:56, September 29, 2010Kkparikh (Talk | contribs)[stable]
(cur)(last)08:15, July 26, 2010Kkparikh (Talk | contribs) (→Business Growth)[stable]
(cur)(last)21:29, July 15, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)21:27, July 15, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)12:16, July 13, 2010Kkparikh (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)12:15, July 13, 2010Kkparikh (Talk | contribs) (→Potential Legal Trouble With Avandia)[stable]
(cur)(last)12:15, July 13, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)12:13, July 13, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)12:12, July 13, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)12:08, July 13, 2010Kkparikh (Talk | contribs) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)09:06, July 13, 2010247WallSt (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)08:35, June 22, 2010Kkparikh (Talk | contribs) (→Business Development)[stable]
(cur)(last)20:37, May 26, 2010Wraasch (Talk | contribs)[stable]
(cur)(last)22:51, April 14, 2010Wraasch (Talk | contribs) (→Comparison to Competitors)[stable]
(cur)(last)12:42, April 13, 2010112.141.44.84 (Talk) (→Pharmaceutical (GBP 27.3 Billion))[stable]
(cur)(last)12:41, April 13, 2010112.141.44.84 (Talk) (→Vaccines (GBP 3.7 Billion))[stable]
(cur)(last)11:30, March 13, 201067.180.11.67 (Talk)[stable]
(cur)(last)06:12, February 14, 201090.199.170.89 (Talk) (→Corporate Overview)[stable]
(cur)(last)21:09, January 20, 2010Wraasch (Talk | contribs)m (→Flu Pandemics/Epidemics)[stable]
(cur)(last)20:59, January 20, 2010Wraasch (Talk | contribs)[stable]
(cur)(last)07:13, December 21, 200986.21.212.91 (Talk) (→Flu Pandemics/Epidemics)[stable]
(cur)(last)07:11, December 21, 200986.21.212.91 (Talk) (→Comparison to Competitors)[stable]
(cur)(last)21:00, December 16, 2009Wraasch (Talk | contribs) (→GSK plans growth in emerging markets)[stable]
(cur)(last)20:53, December 16, 2009Wraasch (Talk | contribs) (→GSK plans growth in emerging markets)[stable]
(cur)(last)20:48, December 16, 2009Wraasch (Talk | contribs) (→Trends and Forces)[stable]
(cur)(last)08:24, November 29, 2009Wraasch (Talk | contribs)[stable]
(cur)(last)14:10, November 12, 2009Wraasch (Talk | contribs)[stable]
(cur)(last)14:03, November 12, 2009155.91.28.231 (Talk) (→Products and Revenue)[stable]
(cur)(last)14:01, November 12, 2009155.91.28.231 (Talk) (→Corporate Overview)[stable]
(cur)(last)15:13, November 8, 2009Wraasch (Talk | contribs) (→Business Growth)[stable]
(cur)(last)11:51, October 10, 2009Wraasch (Talk | contribs)[stable]
(cur)(last)11:33, October 10, 2009Wraasch (Talk | contribs)m (→Patent expirations)[stable]
(Latest | Earliest) View (previous 50) (next 50)
Retrieved from "http://www.wikinvest.com/stock/GlaxoSmithKline_(GSK)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki